A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Respiratory infections are the third leading cause of death worldwide. Illness is caused by pathogen replication and disruption of airway homeostasis by excessive expansion of cell numbers. One strategy to prevent lung immune–mediated damage involves reducing the cellular burden. To date, antiinflammatory strategies have affected both antigen-specific and naive immune repertoires. Here we report a novel form of immune intervention that specifically targets recently activated T cells alone. OX40 (CD134) is absent on naive T cells but up-regulated 1–2 d after antigen activation. OX40–immunoglobulin fusion proteins block the interaction of OX40 with its ligand on antigen-presenting cells and eliminate weight loss and cachexia without preventing virus clearance. Reduced proliferation and enhanced apoptosis of lung cells accompanied the improved clinical phenotype. Manipulation of this late costimulatory pathway has clear therapeutic potential for the treatment of dysregulated lung immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“According to the World Health Organization lower respiratory tract infections are the third most common cause of death (1).”
BackgroundFlynn, S., Toellner, K.-M., Raykundalia, C., Goodall, M., & Lane, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.297 · Cited by 351 · cited 1×
“OX40 imparts a survival signal to the T cell preventing activation-induced cell death (7) but up-regulating anti-apoptosis gene expression (8) and cytokine production (9).”
Background
Cited by
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
“(65); ligation on activated T cells reduces pulmonary eosinophilia during Cryptococcus neoformans”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 747
The cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y.-H., & Yang, Z.-Q. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 716
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Croft, M. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101243 · Cited by 548
Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 511
Pulè, M. A., Straathof, K. C., Dotti, G., Heslop, H. E., Rooney, C. M., & Brenner, M. K. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.016 · Cited by 487
A question of self‐preservation: immunopathology in influenza virus infection
La Gruta, N. L., Kedzierska, K., Stambas, J., & Doherty, P. C. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100026 · Cited by 459
Regulating the adaptive immune response to respiratory virus infection
Braciale, T. J., Sun, J., & Kim, T. S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3166 · Cited by 361
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
Sugamura, K., Ishii, N., & Weinberg, A. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1371 · Cited by 335
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Hendriks, J., Xiao, Y., Rossen, J. W. A., van der Sluijs, K. F., Sugamura, K., Ishii, N., & Borst, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1665 · Cited by 212
“OX40-Ig fusion protein was recently shown to reduce both CD4 and CD8 T cell numbers in the lungs of mice primed with HKx31 influenza virus, which was the first in vivo evidence that OX40 can promote primary CD8 T cell responses (33).”
BackgroundHow do viral infections predispose patients to bacterial infections?
Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183
Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection
Duan, S., & Thomas, P. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00025 · Cited by 179
“org OX40L/OX40 signaling during IAV infection by administration of an OX40 fusion protein significantly reduced the magnitude of both IAV-specific CTL and CD4+ T-cell responses (78).”
BackgroundCD4 T cell responses to influenza infection
Brown, D. M., Román, E., & Swain, S. L. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.02.004 · Cited by 174
An IL-7 Fusion Protein That Shows Increased Thymopoietic Ability
Henson, S. M., Snelgrove, R., Hussell, T., Wells, D. J., & Aspinall, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.4112 · Cited by 55
Self-citation
Metadata
- Authors
- Humphreys, I. R., Walzl, G., Edwards, L., Rae, A., Hill, S., & Hussell, T.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-10-20
- Volume
- 198
- Issue
- 8
- Pages
- 1237-1242
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2144065002
- Cited by
- 105
- References
- 2
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.